175 related articles for article (PubMed ID: 29802959)
1. Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism.
Domingo-Espín J; Nilsson O; Bernfur K; Del Giudice R; Lagerstedt JO
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2822-2834. PubMed ID: 29802959
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.
Brown BE; Nobecourt E; Zeng J; Jenkins AJ; Rye KA; Davies MJ
PLoS One; 2013; 8(5):e65430. PubMed ID: 23741493
[TBL] [Abstract][Full Text] [Related]
3. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion.
Fryirs MA; Barter PJ; Appavoo M; Tuch BE; Tabet F; Heather AK; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1642-8. PubMed ID: 20466975
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
Del Giudice R; Domingo-Espín J; Iacobucci I; Nilsson O; Monti M; Monti DM; Lagerstedt JO
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3038-3048. PubMed ID: 28887204
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I primes beta cells to increase glucose stimulated insulin secretion.
Nilsson O; Del Giudice R; Nagao M; Grönberg C; Eliasson L; Lagerstedt JO
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165613. PubMed ID: 31765698
[TBL] [Abstract][Full Text] [Related]
6. A short peptide of the C-terminal class Y helices of apolipoprotein A-I has preserved functions in cholesterol efflux and in vivo metabolic control.
Edmunds SJ; Liébana-García R; Stenkula KG; Lagerstedt JO
Sci Rep; 2020 Oct; 10(1):18070. PubMed ID: 33093642
[TBL] [Abstract][Full Text] [Related]
7. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.
Nobecourt E; Davies MJ; Brown BE; Curtiss LK; Bonnet DJ; Charlton F; Januszewski AS; Jenkins AJ; Barter PJ; Rye KA
Diabetologia; 2007 Mar; 50(3):643-53. PubMed ID: 17216278
[TBL] [Abstract][Full Text] [Related]
8. ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice.
Edmunds SJ; Liébana-García R; Nilsson O; Domingo-Espín J; Grönberg C; Stenkula KG; Lagerstedt JO
Diabetologia; 2019 Jul; 62(7):1257-1267. PubMed ID: 31069401
[TBL] [Abstract][Full Text] [Related]
9. In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.
Cochran BJ; Ryder WJ; Parmar A; Tang S; Reilhac A; Arthur A; Charil A; Hamze H; Barter PJ; Kritharides L; Meikle SR; Gregoire MC; Rye KA
Diabetologia; 2016 Sep; 59(9):1977-84. PubMed ID: 27193916
[TBL] [Abstract][Full Text] [Related]
10. Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus.
Liu D; Ji L; Zhao M; Wang Y; Guo Y; Li L; Zhang D; Xu L; Pan B; Su J; Xiang S; Pennathur S; Li J; Gao J; Liu P; Willard B; Zheng L
J Mol Cell Cardiol; 2018 Sep; 122():47-57. PubMed ID: 30092227
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage.
Burgess JW; Frank PG; Franklin V; Liang P; McManus DC; Desforges M; Rassart E; Marcel YL
Biochemistry; 1999 Nov; 38(44):14524-33. PubMed ID: 10545174
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-I increases insulin secretion and production from pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism.
Cochran BJ; Bisoendial RJ; Hou L; Glaros EN; Rossy J; Thomas SR; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2261-7. PubMed ID: 25147338
[TBL] [Abstract][Full Text] [Related]
13. Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice.
Stenkula KG; Lindahl M; Petrlova J; Dalla-Riva J; Göransson O; Cushman SW; Krupinska E; Jones HA; Lagerstedt JO
Diabetologia; 2014 Apr; 57(4):797-800. PubMed ID: 24442447
[TBL] [Abstract][Full Text] [Related]
14. Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.
Kashyap SR; Osme A; Ilchenko S; Golizeh M; Lee K; Wang S; Bena J; Previs SF; Smith JD; Kasumov T
J Clin Endocrinol Metab; 2018 Feb; 103(2):388-396. PubMed ID: 29077935
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity.
Salminen A; Åström P; Metso J; Soliymani R; Salo T; Jauhiainen M; Pussinen PJ; Sorsa T
FASEB J; 2015 Apr; 29(4):1435-45. PubMed ID: 25550459
[TBL] [Abstract][Full Text] [Related]
16. Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus.
Duvillard L; Pont F; Florentin E; Gambert P; Vergès B
Atherosclerosis; 2000 Sep; 152(1):229-37. PubMed ID: 10996359
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.
Lehti M; Donelan E; Abplanalp W; Al-Massadi O; Habegger KM; Weber J; Ress C; Mansfeld J; Somvanshi S; Trivedi C; Keuper M; Ograjsek T; Striese C; Cucuruz S; Pfluger PT; Krishna R; Gordon SM; Silva RA; Luquet S; Castel J; Martinez S; D'Alessio D; Davidson WS; Hofmann SM
Circulation; 2013 Nov; 128(22):2364-71. PubMed ID: 24170386
[TBL] [Abstract][Full Text] [Related]
18. Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant.
Dalla-Riva J; Lagerstedt JO; Petrlova J
PLoS One; 2015; 10(11):e0143915. PubMed ID: 26605794
[TBL] [Abstract][Full Text] [Related]
19. Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages.
Tabet F; Lambert G; Cuesta Torres LF; Hou L; Sotirchos I; Touyz RM; Jenkins AJ; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1192-200. PubMed ID: 21330603
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.
Hoang A; Murphy AJ; Coughlan MT; Thomas MC; Forbes JM; O'Brien R; Cooper ME; Chin-Dusting JP; Sviridov D
Diabetologia; 2007 Aug; 50(8):1770-9. PubMed ID: 17579831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
